Vasospastic Angina Diagnosed by the Spasm Provocation Test with the Combined Use of the Acetylcholine and Ergonovine Provocation Tests

por Matsumura, Mirai, Oshita, Chikage, Fujii, Yuichi, Ueda, Tomohiro, Teragawa, Hiroki
Publicado 2019

Dose reduction of docetaxel avoids the usage of pegfilgrastim in docetaxel plus ramucirumab therapy for recurrent nonsmall cell lung cancer

por Hamai, Kosuke, Miyaka, Shinya, Tada, Shinpei, Fujita, Suguru, Hirakawa, Tetsu, Matsumura, Mirai, Ueno, Sayaka, Tanimoto, Takuya, Ishikawa, Nobuhisa
Publicado 2023

Need for a high-specificity test for confirming weakly positive result in an immunochromatographic SARS-CoV-2-specific antigen test: A case report

por Tanimoto, Takuya, Matsumura, Mirai, Tada, Shinpei, Fujita, Suguru, Ueno, Sayaka, Hamai, Kosuke, Omoto, Takuji, Maeda, Hiroyuki, Nishisaka, Takashi, Ishikawa, Nobuhisa
Publicado 2021

First‐line immune checkpoint therapy in metastatic squamous cell lung cancer harboring both EGFR mutation and high expression of PD‐L1: A case report

por Hamai, Kosuke, Tanahashi, Hiroki, Ueno, Sayaka, Konishi, Hanae, Matsumura, Mirai, Nomura, Akio, Nakamoto, Kanako, Isoyama, Shoko, Tanimoto, Takuya, Shoda, Hiroyasu, Ishikawa, Nobuhisa
Publicado 2020

Switching Treatment from Mepolizumab to Benralizumab for Elderly Patients with Severe Eosinophilic Asthma: A Retrospective Observational Study

por Isoyama, Shoko, Ishikawa, Nobuhisa, Hamai, Kosuke, Matsumura, Mirai, Kobayashi, Hiroki, Nomura, Akio, Ueno, Sayaka, Tanimoto, Takuya, Maeda, Hiroyuki, Iwamoto, Hiroshi, Hattori, Noboru
Publicado 2022

Effect of baricitinib in patients with coronavirus disease 2019 and respiratory failure: A propensity score-matched retrospective cohort study

por Tanimoto, Takuya, Tada, Shinpei, Fujita, Suguru, Hirakawa, Tetsu, Matsumura, Mirai, Isoyama, Shoko, Ueno, Sayaka, Hamai, Kosuke, Tsuji, Naoki, Hirosawa, Hideyasu, Taniguchi, Tomohiro, Okamoto, Takeshi, Omoto, Takuji, Kusunoki, Shinji, Maeda, Hiroyuki, Ishikawa, Nobuhisa
Publicado 2022

Phase 2 study of first‐line pembrolizumab monotherapy in elderly patients with non‐small‐cell lung cancer expressing high PD‐L1

por Masuda, Takeshi, Fujitaka, Kazunori, Suzuki, Tomoko, Hamai, Kosuke, Matsumoto, Naoko, Matsumura, Mirai, Isoyama, Shoko, Ueno, Sayaka, Mito, Mineyo, Yamaguchi, Kakuhiro, Sakamoto, Shinjiro, Kawano, Reo, Masuda, Ken, Nishino, Ryohei, Ishikawa, Nobuhisa, Yamasaki, Masahiro, Hattori, Noboru
Publicado 2022